IVS-3001

· MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IVS-3001, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors [Phase 1, Phase 2]

See pricing